Daphne Zohar
Daphne Zohar is the Founder, CEO and Board Member of Seaport Therapeutics. Previously, she was the Founder, CEO and Board Member of PureTech Health (Nasdaq: PRTC), where she also co-founded PureTech’s entities, including Karuna Therapeutics (Nasdaq: KRTX), which was acquired by Bristol Myers Squibb for $14 billion. A successful entrepreneur, Ms. Zohar created PureTech, assembling a leading team to help implement her vision for the company, and was a key driver in fundraising, business development and establishing the underlying programs and platforms that resulted in PureTech’s productive R & D engine, which led to 28 new medicines being advanced via its Wholly Owned Pipeline and Founded Entities, including Cobenfy (KarXT) that has just received US FDA approval. PureTech’s track record of clinical success is approximately six times better than the industry average and 80
percent of the clinical studies run by PureTech and its Founded Entities have been successful
Ms. Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources, including EY, Goldman Sachs, Fierce Pharma, BioWorld, MIT Technology Review, The Boston Globe and Scientific American. She serves on the BIO (Biotechnology Innovation Organization) Board Executive Committee as well as the Health Section Committee. Ms. Zohar is a member of the Duke-Margolis Center Policy Roundtable on the Inflation Reduction Act (IRA) and the Health Affairs IRA Observatory.
About the Sisterhood
The Biotech CEO Sisterhood is a vibrant community dedicated to championing the success of women leaders in the biopharma industry. Rooted in a culture of mutual support and authenticity, the Sisterhood aims to inspire and uplift women while driving meaningful conversations and impact across the industry. As part of our commitment to nurturing the current and future generations of biotech leaders, the Sisterhood hosts summits, local events, and educational sessions. These programs encourage dialogue about the challenges facing women in biotech, share best practices, and enhance leadership effectiveness. Since its inception in 2022, the Biotech CEO Sisterhood has grown to 300+ members. To follow our progress and learn more, please follow us on LinkedIn.
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.
​
​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.